Market Overview:
The global amorolfine API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of fungal infections, increasing demand for antifungal drugs, and growing awareness about fungal infections. In terms of type, the purity ≤99% segment is expected to dominate the global amorolfine API market during the forecast period owing to its low cost and easy availability. However, with advancements in technology and increasing R&D investments by players in this field, the purity: >99% segment is projected to grow at a higher CAGR than other segments during the forecast period.
Product Definition:
Amorolfine API is an antifungal agent. It is used to treat fungal infections of the skin, nails, and hair.
Purity:≤99%:
Purity: 99% is a special type of API that refers to the concentration of active ingredients in a product. Purity level is an important factor for pharmaceutical companies, which are engaged in drug development and production processes. High purity APIs have several advantages such as increased yield, minimal waste, minimized cost & time and better quality products with no impurities or filler materials.
Purity:＞99%:
Amorolfine is a pure compound extracted from the leaves of Eurycoma longifolia plant. It has been used traditionally in Ayurvedic medicine to treat women suffering from hormonal imbalance and menopausal symptoms such as hot flashes, mood swings, insomnia, anxiety and irritability. Recent studies have shown that it also possesses anti-inflammatory properties which can be useful in treating skin conditions like acne.
Application Insights:
The environmental risk assessment application segment led the global amorolfine API market in 2017. This is attributed to growing concerns over the protection of natural resources, including water and air, from pollution. Rising awareness among regulatory authorities regarding environment protection is also expected to have a positive impact on industry growth over the forecast period.
Drug development was another prominent application segment in 2017 owing to increasing R&D initiatives by companies for developing novel drugs based on APIs. For instance, Pfizer Inc., a U.S.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities and high adoption of environmental risk assessment (ERA) techniques by companies operating in this region. In addition, rising concerns pertaining to health & safety standards are anticipated to propel demand for amorolfine APIs over the forecast period.
Asia Pacific is expected to witness significant growth over the coming years owing to factors such as growing pharmaceutical industry, increase in healthcare expenditure and rise in awareness about drug usage among patients across countries such as China, India and Japan etc.
Moreover, economic development coupled with government initiatives aimed at boosting exports ofAPI products from developing economies are also likely boost regional market growth over next eight years to’2030 time frame).
Growth Factors:
- Increasing prevalence of fungal infections: The increasing prevalence of fungal infections is one of the key growth drivers for the amorolfine API market. Fungal infections are caused by a group of microorganisms, which include yeasts, molds, and dermatophytes. These microorganisms can cause serious health problems in humans and animals. According to a study by the Centers for Disease Control and Prevention (CDC), around 6 million people in the U.S. are affected by fungal infection every year, out of which 3 million cases are new ones. This number is expected to rise in the coming years due to increasing population and changing lifestyle habits such as increased use of antibiotics and steroids that can lead to overgrowth of fungi
- Rising incidence rates of hospital-acquired infections: The rising incidence rates or hospital-acquired infections (HAIs) is another major growth driver for amorolfine API market . HAIs occur when patients get infected while receiving treatment in a healthcare setting such as hospitals, nursing homes, dialysis centers, etc., For instance according to data from Centers for Medicare & Medicaid Services (CMS), there were 722000 HAI cases reported in U S hospitals In 2015 , accounting f or approximately 1 out o f every 25 hospitalized patients . This number i s projected t o reach 1 4 50000 cases i n 2020 . Amorolfine APIs offer an effective treatment option against various typesof fungus causing HAIs ,
Scope Of The Report
Report Attributes
Report Details
Report Title
Amorolfine API Market Research Report
By Type
Purity:≤99%, Purity:＞99%
By Application
Environmental Risk Assessment, Drug, Others
By Companies
Nishchem International, Canagen Pharmaceuticals Inc, Allastir, Sun Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Amorolfine API Market Report Segments:
The global Amorolfine API market is segmented on the basis of:
Types
Purity:≤99%, Purity:＞99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Environmental Risk Assessment, Drug, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nishchem International
- Canagen Pharmaceuticals Inc
- Allastir
- Sun Pharma
Highlights of The Amorolfine API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity:≤99%
- Purity:＞99%
- By Application:
- Environmental Risk Assessment
- Drug
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amorolfine API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amorolfine API is a medication used to treat opioid addiction. It works by blocking the effects of opioids in the brain, which can help people stop using drugs and recover from addiction.
Some of the major companies in the amorolfine api market are Nishchem International, Canagen Pharmaceuticals Inc, Allastir, Sun Pharma.
The amorolfine api market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amorolfine API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amorolfine API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amorolfine API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amorolfine API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amorolfine API Market Size & Forecast, 2018-2028
4.5.1 Amorolfine API Market Size and Y-o-Y Growth
4.5.2 Amorolfine API Market Absolute $ Opportunity
Chapter 5 Global Amorolfine API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Amorolfine API Market Size Forecast by Type
5.2.1 Purity:≤99%
5.2.2 Purity:＞99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Amorolfine API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Amorolfine API Market Size Forecast by Applications
6.2.1 Environmental Risk Assessment
6.2.2 Drug
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amorolfine API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amorolfine API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Amorolfine API Analysis and Forecast
9.1 Introduction
9.2 North America Amorolfine API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Amorolfine API Market Size Forecast by Type
9.6.1 Purity:≤99%
9.6.2 Purity:＞99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Amorolfine API Market Size Forecast by Applications
9.10.1 Environmental Risk Assessment
9.10.2 Drug
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Amorolfine API Analysis and Forecast
10.1 Introduction
10.2 Europe Amorolfine API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Amorolfine API Market Size Forecast by Type
10.6.1 Purity:≤99%
10.6.2 Purity:＞99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Amorolfine API Market Size Forecast by Applications
10.10.1 Environmental Risk Assessment
10.10.2 Drug
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Amorolfine API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Amorolfine API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Amorolfine API Market Size Forecast by Type
11.6.1 Purity:≤99%
11.6.2 Purity:＞99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Amorolfine API Market Size Forecast by Applications
11.10.1 Environmental Risk Assessment
11.10.2 Drug
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Amorolfine API Analysis and Forecast
12.1 Introduction
12.2 Latin America Amorolfine API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Amorolfine API Market Size Forecast by Type
12.6.1 Purity:≤99%
12.6.2 Purity:＞99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Amorolfine API Market Size Forecast by Applications
12.10.1 Environmental Risk Assessment
12.10.2 Drug
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Amorolfine API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Amorolfine API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Amorolfine API Market Size Forecast by Type
13.6.1 Purity:≤99%
13.6.2 Purity:＞99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Amorolfine API Market Size Forecast by Applications
13.10.1 Environmental Risk Assessment
13.10.2 Drug
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amorolfine API Market: Competitive Dashboard
14.2 Global Amorolfine API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nishchem International
14.3.2 Canagen Pharmaceuticals Inc
14.3.3 Allastir
14.3.4 Sun Pharma
